CIK 0001653087 · Accelerated filer<br>Smaller reporting company
Alector, Inc.
Sign in to watch- Ticker
- ALEC
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 822933343
- Phone
- 415-231-5660
- Business address
- 131 OYSTER POINT BLVD., SUITE 600, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- Alector LLC
- 4 Grant or award Director acquired 9,459 shares (grant or award)
- 4 Grant or award Director acquired 9,459 shares (grant or award)
- 4 Grant or award Director acquired 9,459 shares (grant or award)
- 4 Grant or award Director acquired 9,459 shares (grant or award)
- 4 Grant or award Director acquired 9,459 shares (grant or award)
- 8-K Event Shareholder vote results
- 4 Open-market sale Chief Development Officer sold 177 shares at $8.71 ($1,542)
- 4 Grant or award Chief Medical Officer acquired 92,250 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- DEFR14A Other DEFR14A
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 8-K Event Executive or director change
- 4 Open-market sale Chief Development Officer sold 287 shares at $15.57 ($4,468)
- 4 Derivatives Options or other derivatives
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-K Report Annual Report
- 8-K Event Results of operations
Page 18 of 32 · 631 filings